Rheumatoid Arthritis

      RheumNow Podcast square
      Is Cannabis Safe? (6.7.2024)
      3 months 4 weeks ago
      Dr. Jack Cush reviews FDA approval, news and journal articles -- and it’s the week before EULAR 2024 in Vienna!!FDA has approved upadacitinib (Rinvoq), for use in pediatric patients (age >2 years…
      JAK or TNF Inhibitor as First Drug for Rheumatoid Arthritis?

      A JAK inhibitor outperformed TNF blockers for substantial

      Dr. John Cush RheumNow

      3 months 4 weeks ago
      JAK or TNF Inhibitor as First Drug for Rheumatoid Arthritis? A JAK inhibitor outperformed TNF blockers for substantially reducing RA symptoms in patients for whom conventional anti-rheumatic drugs had failed, a pragmatic head-to-head trial found. https://t.co/7BhFSwb1Ns https://t.co/Hf31OPgE0M

      Podcasts

      • Stop Counting Bugs (10.4.2024)
      • RA Risk Radar: Heart Disease, Infection, and Malignancy Sponsored by AbbVie Medical Affairs
      • Which One Is The Loneliest Number (9.27.2024)

      Catch up on Conference Podcasts

      Featured Video

      Do you get our email newsletter?

      Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

      Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

      Copyright {{ 'now'|date('Y') }} All Rights Reserved.